Skip to main content

Table 2 Patients’ characteristics according to the time of initiation of preoperative anticoagulation therapy

From: Incidence of venous thromboembolism and hemorrhage related safety studies of preoperative anticoagulation therapy in hip fracture patients undergoing surgical treatment: a case–control study

Characteristics

Group A

Group B

Group C

Group D

Total

P value

(n=54)

(n=57)

(n=15)

(n=7)

(n=133)

Basic Information

      

Age (years),mean ± SD

76±11

75±8

76±8

79±4

76±9

0.647

Gender

      

 Male

22

20

7

3

52

 

 Female

32

37

8

4

81

 

Body weight (kg), mean ± SD

58.31±11.55

58.96±12.01

61±9.96

57.71±9.36

58.87±11.34

 

Body mass index, mean ± SD

22.08±3.94

22.28±3.68

22.46±2.71

22.08±3.94

21.83±58.10

0.971

Comorbid conditions, n (%)

      

  Hypertension

11 (20.37)

13 (22.81)

8 (53.33)

4 (57.14)

36 (27.06)

 

  Diabetes

9 (16.67)

14 (24.56)

7 (46.67)

5 (71.43)

33 (24.81)

 

  Congestive heart failure

3 (5.56)

1 (1.75)

0 (0)

1 (14.29)

5 (3.76)

 

  Varicose veins

2 (3.70)

1 (1.75)

1 (6.67)

0 (0)

4 (3.01)

 

  Currently active cancer

0 (0)

0 (0)

0 (0)

0 (0)

0 (0)

 

  Paralysis of lower limbs

2 (3.70)

4 (7.02)

1 (6.67)

0 (0)

7 (5.26)

 

  Atrial fibrillation

5 (9.26)

4 (7.02)

1 (6.67)

1 (14.29)

11 (8.27)

 

  Prior stroke or TIA

2 (3.70)

4 (7.02)

1 (6.67)

0 (0)

7 (5.26)